CORT News

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Pomerantz LLP Informs Shareholders of Securities Class Action Against Corcept Therapeutics Incorporated – CORT

April 21, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CORT

CORT INVESTOR ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm

Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors

Pomerantz LLP Informs Shareholders of Class Action Filing Against Corcept Therapeutics Incorporated – CORT

CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm